Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,941 public trials 2,019 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis

NCT07335887

Conditions: AL Amyloidosis (AL), Amyloidosis, Immune System Diseases, +11 more
Locations: Peking University First Hospital Beijing, China

Peking University People's Hospital Beijing, China

The first Affiliated Hospital of Xi'an Jiaotong University Xi'an, China

View Trial Details

Recruiting

Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease

NCT07272499

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

NCT03258567

Conditions: DNA Virus Infections, Disorders, Lymphoproliferative, Epstein-Barr Virus Infections, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

NCT02682667

Conditions: Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +31 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT07020533

Conditions: Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +38 more
Locations: City of Hope Medical Center Duarte, California, United States

Northside Hospital Atlanta, Georgia, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Genetic Studies of Chronic Active Epstein-Barr Disease

NCT00032513

Conditions: Chronic Active Epstein-Barr Virus, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

NCT06150664

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +37 more
Locations: D&H Cancer Research Center Margate, Florida, United States

Florida Cancer Specialists - Lake Nona Orlando, Florida, United States

Florida Cancer Specialists - Sarasota Sarasota, Florida, United States

University Cancer & Blood Center Athens, Georgia, United States

View Trial Details

Recruiting

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

NCT01087333

Conditions: Adult T Cell Lymphoma (ATL), Anemia, Anemia, Hemolytic, +39 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

NCT03223610

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +17 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma

NCT07730515

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions